Suze Berkhout
Dr. Suze Berkhout is an early career clinician-investigator and practicing inpatient psychiatrist. She completed a combined MD/PhD at the University of British Columbia. Her program of research in feminist philosophy of science/STS utilizes ethnographic and narrative qualitative methods to explore social and cultural issues impacting access and navigation through health care systems. She focuses on the epistemic and ontological importance of lived experience in relation to knowledge in/of medicine, and related to mental health especially. She carries out this work in diverse populations, including in treatment resistance in mental health, early psychosis, transplant medicine, and Placebo/Nocebo Studies. She is also involved in the development and evaluation of mental health supports to health care workers in relation to the COVID-19 pandemic, bringing a critical humanities lens to this area of work as well. Dr. Berkhout has received grants from the New Frontiers Research Fund (NFRF), the University of Toronto, UHN/MSH AMO Innovation Fund, and the U of T Department of Psychiatry. She is a co-investigator on projects funded by CIHR, SSHRC, and WCH Innovation Fund.
Kathleen Sheehan
Dr. Kathleen Sheehan is a consultation-liaison and inpatient psychiatrist with the University Health Network (UHN) Centre for Mental Health, Clinician Investigator at The Institute for Education Research at UHN, and Assistant Professor in the University of Toronto Department of Psychiatry. She is also Director of the Department’s Clinician Scholar Program. Before attending the Michael G. DeGroote School of Medicine at McMaster University, she was awarded a doctorate in social psychiatry and master’s degree in neuroscience at the University of Oxford. She completed her psychiatry residency training, as part of the Clinician Scientist Stream, at the University of Toronto. Her research focuses on quality of care, particularly for individuals with co-occurring physical and mental health issues. Working with colleagues across specialties and disciplines, she investigates how to improve gap in care. She has received grants from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, and institutional funding from the University of Toronto, UHN/MSH AMO Innovation Fund, and Department of Psychiatry. She is increasingly interested in the use of mixed methods and qualitative approaches to understanding care provision challenges in these areas. Dr. Sheehan advocates for system-wide improvement in physical and mental health care through medical and public education. She is Vice President and Continuing Professional Development Lead of the Canadian Academy of Psychosomatic Medicine, co-lead of the Extension of Community Health Outcomes (ECHO) Integrated Mental and Physical Health Care program funded by the Ministry of Health, and member of the Health Quality Ontario Delirium Standards Committee.
Dr. Lindsey MacGillivray is an Assistant Professor at the University of Toronto and staff psychiatrist at the University Health Network. She completed an MD/PhD program at McMaster University, with a research specialization in neuroscience, followed by a psychiatry residency at the University of Toronto. Dr. MacGillivray is a clinician-teacher with academic interests in the fields of neuropsychiatry and psychosomatic illness. She works within the medical psychiatry and inpatient psychiatry programs at the Toronto Western and Toronto General Hospitals and is the Clinical Lead for the Functional Movement Disorders Integrated Care Clinic at the Toronto Rehabilitation Institute.
Lindsey MacGillivray
Daniel Buchman’s program of research explores ethical issues at the intersection of clinical practice and public health. His primary areas of research interest include ethical issues related to mental health, substance use, and chronic pain. Themes related to stigma, identity, moral responsibility, and compassion feature prominently in his work, and he has a longstanding teaching interest in empirical approaches to bioethics. Some of Daniel's current research interests are in the areas of ethics of machine learning and big data in mental health, neuroethics, and psychedelic-assisted mental health care. His research draws upon a transdisciplinary toolkit of conceptual and empirical research methods including conceptual bioethics, theory-driven qualitative interviews and focus groups, surveys, and knowledge syntheses.
Dan Buchman
Dr. Daniel Rosenbaum is an attending psychiatrist at UHN as well as the Inner City Health Associates (ICHA) in Toronto. He is a clinical lecturer in the Department of Psychiatry at the University of Toronto. He works on the IMPACT Assertive Community Treatment team at UHN, as well as the Palliative Education and Care for the Homeless (PEACH) team through ICHA. He is interested in palliative care and end-of-life issues among marginalized groups, including people with Severe and Persistent Mental Illness. Daniel is a certified CALM therapist (Managing Cancer and Living Meaningfully) and has received training in ketamine-assisted psychotherapy. He has also completed the Multidisciplinary Association of Psychedelic Studies MDMA Therapy Training Program. Daniel is a co-founder and faculty member at the Nikean Psychedelic Psychotherapy Research Centre (NPRRC) at UHN. Together with Drs. Sarah Hales and Emma Hapke, he is a co-Principal Investigator on the PEARL (Psilocybin-assisted Existential, Attachment, and RelationaL) therapy research program; PEARL is a novel psychedelic-assisted psychotherapy for patients with advanced disease and their caregivers. Currently, Daniel’s main interests in the field of psychedelic therapy surround the care of people facing advanced/life-threatening illness, as well as the risks and benefits of experiential training. Daniel is also interested in the mental health impacts of the climate crisis.